Eli Lilly weight loss pill orforglipron clears trial, paving way for approval

Science

Eli Lilly Weight Loss Pill Orforglipron Clears Trial, Paving Way For Approval

By CNBC

Eli Lilly on Tuesday said its daily weight loss pill helped patients with obesity and Type 2 diabetes shed weight in a late-stage trial, meeting the study's main goal and clearing the way for the company to file for approval of the drug globally. The ...Read more